Peringkat dalam Saham
#33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Harga Saham
$0.5475
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$6.71M
Perdagangan 20/20 Biolabs Inc. (AIDX)
Harga AIDX dengan kapitalisasi pasar B
Kapitalisasi pasar dari 20/20 Biolabs Inc.(AIDX)
Kapitalisasi Pasar: $6.71M
Per August 2026, 20/20 Biolabs Inc. memiliki kapitalisasi pasar sebesar $6.71M. Ini menjadikan 20/20 Biolabs Inc. sebagai perusahaan 33864th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar 20/20 Biolabs Inc. dari 2026 hingga 2026
AIDX dibandingkan dengan 5 teratas stocks paling populer
| Harga AIDX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+81,276,656.64%
|
|
|
|
|
$4.490T
|
+66,937,378.02%
|
|
|
|
|
$4.162T
|
+62,053,302.40%
|
|
|
|
|
$3.676T
|
+54,807,023.79%
|
|
|
|
|
$2.833T
|
+42,235,061.84%
|
